Abstract Determination of oxidative metabolism in the brain using in vivo 13 C NMR spectroscopy ( 13 C MRS) typically requires repeated blood sampling throughout the study to measure blood glucose concentration and fractional enrichment (input function). However, drawing blood from small animals, such as young rats, placed deep inside the magnet is technically difficult due to their small total blood volume. In the present study, a custom-built animal holder enabled temporary removal of the animal from the magnet for blood collection, followed by accurate repositioning in the exact presampling position without degradation of B 0 shimming. 13 C label incorporation into glutamate C4 and C3 positions during a 120 min [1,6-13 C 2 ] glucose infusion was determined in 28-day-old rats (n = 4) under a-chloralose sedation using localized, direct-detected in vivo 13 C MRS at 9.4T. The tricarboxylic acid cycle activity rate (V TCA ) determined using a one-compartment metabolic modeling was 0.67 ± 0.13 lmol/g/min, a value comparable to previous ex vivo studies. This methodology opens the avenue for in vivo measurements of brain metabolic rates using 13 C MRS in small animals.
Introduction
As in the mature brain, glucose is the principal energy substrate for the developing human and rat brains. In both species, the cerebral glucose transport and utilization increases rapidly after birth, paralleling the structural and functional brain maturation [1] [2] [3] . Most of the transported glucose is oxidatively metabolized through the tricarboxylic acid (TCA) cycle in the brain [2] . 13 C NMR spectroscopy ( 13 C MRS) combined with metabolic modeling is an established method for assessing oxidative glucose metabolism in the adult human and animal brains in vivo [4] [5] [6] [7] [8] . In this method, 13 C-enriched glucose, typically labeled at C1 and/or C6 positions, is intravenously infused and the dynamic incorporation of 13 C label in cerebral metabolites is monitored using in vivo MRS. The TCA cycle rate (V TCA ) is determined using metabolic modeling (Reviewed in [9] [10] [11] ).
Thus, far, 13 C NMR studies in small rodents, such young rats, have been limited to ex vivo analysis of the brain tissue [12] [13] [14] [15] . In this method, after administering labeled glucose, small groups of animals are killed at predetermined intervals for determining 13 C label incorporation in brain metabolites. While such studies permit assessment in Electronic supplementary material The online version of this article (doi:10.1007/s11064-011-0519-x) contains supplementary material, which is available to authorized users. conscious animals and have provided important insights into glucose metabolism during normal development and in neuropathologies, they require large sample sizes, and the results may be confounded by inter-animal variations, tissue preparation [14] and postmortem extraction artifacts [9, 10] . In vivo 13 C MRS overcomes these problems by tracking the entire time course of 13 C label incorporation in the same animal.
Even when in vivo 13 C MRS has been possible in small rodents [16] , metabolic modeling has remained a challenge. Metabolic modeling typically requires frequent blood sampling throughout the study to measure plasma glucose concentration and 13 C fractional enrichment (FE) (input function). When animals are placed deep inside the magnet, long vascular catheters are necessary for bringing the blood to the opening of the magnet bore for collection. Whereas the actual blood volume required for analysis is small (0.1-0.2 ml per sample), a much larger volume (typically, 1 ml) is necessary to fill the catheters (''dead volume''), which is subsequently returned to the animal. While such a strategy is feasible in adult rats with a total blood volume of *20 ml, frequent drawing of 1-1.5 ml of blood is not possible in small rodents because of their small total blood volume. The difficulty in measuring the input function has hindered the application of in vivo 13 C MRS and metabolic modeling in small rodents.
In a recent study, Valette et al., showed that metabolic modeling is possible without the knowledge of input function, provided that steady-state plasma FE is achieved rapidly with the infusion and remains constant for the duration of the experiment [17] . However, unlike in bigger animals or humans, it is difficult to achieve such a stable FE in small rodents, and the reliable knowledge of the exact input function in each individual animal becomes necessary for modeling.
In the present study, we measured the glucose metabolic rates in the brain of 28-day-old rats using in vivo 13 C MRS. Rats of this age have yet to achieve physical, sexual and neurodevelopmental maturity and are used to model neurological disorders of young children [18] [19] [20] . The body weight at this age is approximately 25-33% of adult rats (100 g vs. 350-450 g) and the total blood volume is approximately 6-8 ml [21] . We overcame the difficulties with blood collection by designing a custom-built animal holder that enabled removal of the animal temporarily from the magnet for blood collection, followed by repositioning in the exact presampling location with high degree of accuracy and reproducibility. This allowed us to briefly remove the rats from the magnet for blood sampling with negligible impact on voxel position and B 0 shimming. Our aim was to establish the feasibility and reliability of this approach for the in vivo assessment of V TCA in small animals.
Experimental Procedure

Animal Preparation
The Institutional Animal Care and Use Committee approved all experiments. 28-day-old Sprague-Dawley rats (n = 4; 102 ± 8 gm, Harlan, Indianapolis, IN, USA) were studied after overnight fasting. Rats were intubated and mechanically ventilated (Kent Scientific, Litchfield, CT, USA) as previously described [22] . One femoral artery and both femoral veins were cannulated using polyurethane catheters (1.2F; Instech Solomon, Plymouth Meeting, PA, USA). The venous catheters were [5 m in length and were used for infusion of glucose and a-chloralose. The arterial catheter was approximately 30 cm long and was used for blood draws. Isoflurane was discontinued and light anesthesia using a-chloralose (40 mg/kg bolus, followed by continuous infusion at 26.8 mg/kg/h) was used for the remainder of the study. Ventilator settings were adjusted based on arterial blood gas and end tidal CO 2 [22] . The rectal temperature was maintained at 37°C using temperature probe (Cole Palmer, Vernon Hills, IL, USA) and thermosensor-regulated warm water circulating in tubes (RTE-101 bath calculator, Thermo NESLAB, Portsmouth, NH, USA).
Animal Holder
A custom-designed animal holder was used (Fig. 1) . The animal holder and the mounting head functioned as a lock and key mechanism that allowed fine rotational adjustment (range: ± 20°). The rat was placed prone in a cradle and the head was secured using bite-bar and ear rods as in our previous studies [23, 24] . The cradle with the rat was placed inside the animal holder and secured using screws. The surface RF coil was secured over the head. The holder with the rat was placed inside the magnet and scout images were obtained. The optimal rotation angle was established by manually rotating the inner ring of the mounting head ( Fig. 1 ). This rotational position was secured using the rotation-tightening knobs and maintained for the duration of the experiment. The anterior-posterior (translational) position was adjusted using the translation adjustment knob on the holder while the translatable locking pin on the holder was anchored in the locking pin bracket on the mounting head and secured using translation-tightening knobs (Fig. 1) . Releasing the locking pin bracket and loosening the translation-tightening knobs allowed withdrawal of the animal holder from the magnet for blood draws. Replacing the holder and locking the translation pin inside the bracket guaranteed repositioning of the head in the exact presampling position with high degree of accuracy and reproducibility.
Glucose Infusion Protocol
Plasma glucose concentration was rapidly raised to hyperglycemia levels [plasma glucose [13.8 mmol/l ([250 mg/dl)] using published protocol [24] . Briefly, a bolus of 99%-enriched [1,6-13 C 2 ] glucose (20% wt/vol; Isotec, St. Louis, MO, USA) was infused over 5 min with the infusion rate decaying 50% each successive min, followed by continuous infusion of 70%-enriched glucose (20% wt/vol) for the remainder of the experiment [24] . Arterial blood samples were collected at 5, 10, 20, 30, 60, 90 and 120 min after the start of infusion for determining blood gases, plasma glucose levels and 13 C FE. For this, the animal holder was withdrawn from the magnet until the indwelling arterial catheter could be accessed. Approximately 150 ll of blood was collected without disturbing the surface RF coil and the position of the rat. After flushing the catheter with heparinized normal saline, the animal holder was replaced inside the magnet and secured in the pre-sampling position. Each instance of removal from the magnet, blood collection and repositioning required approximately 2 min. Plasma glucose was determined using the glucose oxidase method (Model GM7 Micro-stat; Analox Instruments, London, United Kingdom). Minor adjustments were made to the infusion rates to maintain plasma glucose between 13.8 and 18 mmol/l (250-325 mg/dl). Plasma 13 C FE was determined using the gas chromatography-mass spectrometry method using published methods [8, 25] .
In Vivo 13 C NMR Spectroscopy
In vivo NMR spectra were acquired from all four rats using a 9.4T/31 cm horizontal bore magnet interfaced to an Inova console (Varian, Palo Alto, CA, USA). The magnet was equipped with gradients reaching 450 mT/m in 200 ls (Resonance Research Inc, Bilerica, MA). The RF coil assembly consisted of a 1 H quadrature surface coil (two loops of 14 mm diameter) and an inner 13 C linearly polarized surface coil (12 mm diameter). Fast spin-echo (FSE) images (echo train length = 8, echo spacing = 15 ms, echo time = 48 ms, field of view = 2.5 cm 9 2.5 cm, matrix = 256 9 256, slice thickness = 1 mm) were acquired to select an 8 9 5 9 9 mm 3 volume of interest (VOI) within the brain. NMR spectra were obtained as described previously [24] . Briefly, all first and second-order shims were adjusted using FAST(EST)MAP, which resulted in an average 1 H water linewidth of 22 Hz in the 360 ll VOI. Localized in vivo 13 C NMR spectra were acquired using a semiadiabatic distortionless enhancement by polarization transfer (DEPT) sequence [8, 24] . Localization was performed on the 1 H magnetization using 3D-ISIS combined with outer volume suppression (OVS). The interpulse delay was 3.8 ms (optimized for J CH = 130 Hz) and the nominal flip angle of the last 1 H pulse was set to 45°in order to simultaneously detect signals from CH, CH 2 , and CH 3 groups. Repetition time was 2.5 s.
1 H decoupling with WALTZ-16 composite was applied during the acquisition time (205 ms, 8, 192 complex points) with a nominal c B 1 /2p of 2 kHz. Data were collected in blocks of 128 scans resulting in a temporal resolution of 5.3 min.
Additionally, to confirm that the procedure for blood collection did not impact the rat's position inside the magnet, FSE images were obtained in sagittal and coronal planes before and after four instances of removal and repositioning inside the magnet in a 28-day-old rat.
Ex Vivo
C NMR Spectroscopy of Brain Extracts
In vivo 13 C time courses were scaled using FE measured in the brain extracts collected at the end of the experiment. At the completion of in vivo MRS, rats were killed using focused microwave fixation (4 kW within 1.0 s; Gerling Applied Engineering, Modesto, CA, USA). The entire brain, excluding cerebellum was removed and digested in Fig. 1 Animal holder used for in vivo 13 C NMR spectroscopy in young rats. The animal holder and the mounting head function as a lock and key mechanism and guarantee fixed rotation angle. The inner ring of the mounting head facilitates fine adjustment of rotation (range: ± 20°) and the animal holder can be secured in this position for the duration of the study by tightening the two diagonally opposite rotation-tightening knobs. The translational (anterior-posterior) position can be adjusted using the fine adjustment knob on the holder while the translatable locking pin is anchored in the locking pin bracket on the mounting head. The optimal position is then secured using two translation-tightening knobs. Releasing the locking pin bracket and loosening the translation-tightening knobs enables removal of the holder from the magnet for blood draw. Returning the holder inside the magnet and locking the translation pin in the bracket guarantees repositioning of the rat in the exact presampling position 3 ml ice-cold perchloric acid (0.9 M). Tissue extracts were prepared as described previously [26] . Briefly, digested brain tissue was centrifuged for 15 min at 4°C. The supernatant was neutralized with 9 M KOH. Metallic ions were removed by adding resin (Chelex Ò 100; Bio-Rad Laboratories, Hercules, CA, USA) to the supernatant, which was then filtered, freeze-dried and resuspended in 10:90 D 2 O:H 2 O solution (pH 7.2 ± 0.1).
The brain extracts were analyzed using 13 C MRS at 14.1T (Varian Unity Inova spectrometer). One-dimensional pulse-acquired 13 C spectra were acquired with Nuclear Overhauser Effect (NOE) enhancement under fully relaxed conditions (TR = 15 s, spectral width 30,000 Hz, acquisition time 1 s and 1 H decoupling with WALTZ-16).
Comparison of spectra acquired with and without NOE showed that NOE enhancement was identical for Glu-C4 and Glu-C3, and therefore, no correction was applied for NOE. The built-in spectrometer software was used to fit resonances after zero-filling to 512 K points and resonances were assigned based on peak position using published values [26] . All chemical-shift values were referenced to lactate (Lac, 21 ppm).
LCModel Analysis
Metabolite concentrations in the in vivo 13 C spectra were determined using LCModel (Provencher, Oakville, Ontario, Canada) [8, 26] . No baseline correction, zero-filling, or time domain filtering were applied prior to LCModel analysis. Basis spectra for metabolites were simulated using a custom-written program (Matlab; The MathWorks, Natick, MA, USA) including 13 C-13 C J-modulation. The relative 13 C concentrations determined by LCModel were converted to absolute 13 C concentrations using the isotopic enrichments measured in the brain extracts at the end point and assuming a glutamate (Glu) concentration of 10 lmol/g, based on previous 1 H MRS data from 28-day-old rats [27] .
Metabolic Modeling
Time courses of 13 C-label incorporation into the Glu-C4 and Glu-C3 positions were analyzed using the one-compartment model using SAAM II software (University of Washington, WA, USA) [8] . In each rat, its own individual dynamic FE time course of plasma glucose was used as input function to fit the in vivo data. In addition to V TCA , V X (exchange rate between a-ketoglutarate and Glu) and V OUT (dilution of labeled 13 C-Lac through exchange with unlabeled Lac) were included as unknown (free) parameters in the fit. To account for the loss of 13 C-labeled glutamine (Gln) through exchange with unlabeled Gln, another fitted parameter (V EFF ) was added for dilution of Gln. The following concentrations were assumed in the model based on previous studies [5, 27] :
Finally, the following fluxes were assumed in the model based on a previous study [5] : V GLN (rate of Gln synthesis) = 0.41 9 V TCA and V GLY (rate of glycolysis) = 0.5 9 V TCA .
All data are presented as mean ± SEM.
Results
All the rats were in stable physiological conditions during the experiment. The arterial blood gas was within normal range: pH, 7.32 ± 0.01, PaO 2 , 143.2 ± 7.0 mm Hg and PaCO 2 , 37.3 ± 1.5 mm Hg. The rectal temperature was maintained at 36.7 ± 0.2°C. Rats were repeatedly removed from the magnet for blood sampling. The custom-designed animal holder ensured repositioning of the animal in the presampling position with high degree of accuracy each time (Supplemental Figure) . This allowed us to measure plasma glucose concentration and FE throughout the study. The infusion protocol rapidly achieved the target plasma glucose [[13.8 mmol/l ([250 mg/dl)], which was maintained for the duration of the experiment (Fig. 2) . The average steady-state plasma 13 C glucose FE was 56 ± 4%. There were inter-animal variations in the reaching steady-state plasma FE (Fig. 2a, b) .
In vivo 13 C NMR spectra acquired during [1,6-13 C 2 ] glucose infusion from a rat are shown in Fig. 3 . As observed in this figure, lipid signals at 30 ppm were absent, suggesting excellent localization. Incorporation of 13 C label into Glu and Gln was evident soon after the start of [1,6-13 C 2 ] glucose infusion (Fig. 3) . Glu-C4, Glu-C3, Gln-C4 and Gln-C3 signal intensity progressively increased over time. The Glu-C4 linewidths in the last spectrum acquired prior to removal from the magnet and the first spectrum collected after repositioning were similar in each rat ( Table 1 ), confirming that the procedure for blood collection did not impact B 0 shimming.
The Glu-
13
C4 and Glu-13 C3 concentrations in the in vivo data were determined using the 13 C isotopic enrichment measured in the brain extracts using ex vivo MRS. The isotopic enrichments in Glu-C4 and Gln-C3 at the end of the study were 40 ± 3 and 27 ± 2%, respectively. The time courses of 13 C label incorporation in Glu-C4 and Glu-C3 were fitted with the one compartment metabolic model (Fig. 4) . The V TCA determined using this method was 0.67 ± 0.13 lmol/g/min.
Discussion
To our knowledge, this is the first study of oxidative glucose metabolism determined in vivo in the young rat brain using 13 C MRS. The V TCA value obtained in the present study is comparable to the value determined using ex vivo methods in rats of comparable age [15] and supports the feasibility and reliability of our method for in vivo assessment of cerebral oxidative metabolism in young rats. With additional studies, this approach may be extended to smaller rodents, such as neonatal rats and transgenic mouse models.
Multiple factors were critical for the successful application of in vivo 13 C MRS in this study. Glucose is an ideal substrate for understanding cerebral oxidative metabolism, since its transport across the blood brain barrier is not dependent upon plasma levels, except during severe hypoglycemia. Administration of glucose labeled in C1 and C6 positions improved sensitivity through greater enrichment in labeled metabolic products, since two molecules of [3- 13 C] pyruvate are produced per molecule of [1,6-13 C 2 ] glucose [10, 16] . Thus, we were able to achieve almost two-fold greater 13 C label incorporation in cerebral glucose (Glc) infusion in a 28-day-old rat (TR = 2.5 s, NT = 256 for each 13 C spectrum). Inset shows the MRI in the coronal plane with the volume of interest from which the spectra were acquired (echo train length = 8, echo spacing = 15 ms, echo time = 48 ms, field of view = 2.5 cm 9 2.5 cm, matrix = 256 9 256, slice thickness = 1 mm). * Refers to removal of the rat for blood draw metabolites, compared with a previous ex vivo study that used [1-13 C] glucose [13] . Additionally, the use of a highfield 9.4T magnet, optimal RF-coil design, efficient B 0 shimming and 1 H decoupling were all important factors contributing to high detection sensitivity [9, 24] and ensured reliable detection of 13 C label in cerebral amino acids in the present study. Excellent three-dimensional localization eliminated any contamination from extracerebral lipid signals. This permitted direct detection at the 13 C frequency and avoided the need for 1 H-observed/ 13 C-edited MRS, which is more sensitive, but is limited by the significant overlap of Glu and Gln resonances [16] .
An accurate knowledge of the time course of plasma glucose and isotopic enrichment (input function) is critical for deriving quantitative data from 13 C MRS using metabolic modeling [26] . A recent study demonstrated that metabolic modeling is possible without the knowledge of input function in large animals (non-human primates) [17] . However, a prerequisite for such analysis is rapid achievement of steady-state plasma FE that stays constant for the duration of the measurement [17] . As demonstrated in Fig. 2 , this may not be possible in small animals. Similarly, parallel bench-top experiments in littermates may help to infer the glycemia state in small rodents undergoing in vivo MRS [16] . However, the individual differences in FE are large enough that the input function needs to be measured for each animal individually. In this context, a key aspect of our study was the ability to collect blood samples from the young rats undergoing in vivo MRS, despite their low blood volume (approximately, 6-8 ml) [21] . The custom-designed animal holder permitted removal of the rats from the magnet for collecting small amount of blood (approximately, 1 ml for the entire experiment) for determining the input function. The high-degree of accuracy achieved while repositioning rats in the presampling location prevented significant degradation of B 0 shimming (Table 1) . Thus, in vivo data could be acquired with minimal interruption and the entire 13 C labeling time course could be monitored in individual rats. Collectively, these technical and procedural refinements allowed us to achieve our goal using approximately 75% fewer animals than previous ex vivo studies in rats of comparable age [14, 15] .
Similar to our previous study in adult rats [24] , the glucose infusion protocol rapidly achieved hyperglycemia. The approximately 55% isotopic enrichment of plasma glucose is higher than the approximately 40% enrichment achieved in previous studies of rats of comparable age [14, 15] and slightly lower than the 62% enrichment achieved in adult rats [5] . Due to the broad chemical shift range of direct 13 C detection, we were able to detect and quantitate the time course of Glu-C4 and Glu-C3 resonances without contamination from Gln resonances in the brain. The approximately 44% enrichment of Glu-C4 is comparable to a previous report in 30-day-old rats [15] . The faster rate of 13 C labeling of Glu-C4, relative to Glu-C3, is similar to previous studies [14, 15] and reflects labeling of the C4 position during the first turn of TCA cycle.
As we performed metabolic modeling using a onecompartment model, the V TCA value in the present study primarily represents neuronal TCA cycle activity [10, 28] . The V TCA value of 0.67 ± 0.13 lmol/g/min in the present study is very similar to the combined (i.e. glutamatergic ? GABAergic) neuronal V TCA value of 0.71 ± 0.07 lmol/g/ min demonstrated using ex vivo 13 C MRS in 30-day-old rats [15] . The V TCA value is also comparable to the values in the unstimulated adult rat brain [5, 6, 29] . This is not surprising, given that brain glucose metabolism approaches adult levels between 28 and 35 days of age in rats [2] .
In summary, assessment of cerebral glucose oxidative metabolism using localized, direct-detected in vivo 13 C MRS is feasible in young rats. This methodology opens the avenue for evaluating brain energy metabolism during normal development and neuropathologies in small animals. 
